Background: Many studies have examined factors associated with the first onset of cannabis use and abuse. Currently, there is relatively little research regarding conditions under which cannabis dependence is more likely to emerge. Although previous studies have examined different potential determinants of cannabis dependence, to our knowledge, a systematic review is lacking. Aims: The study aims to identify recent findings regarding psychosocial determinants of cannabis dependence and to summarize them systematically. Methods: A literature search in 4 databases - Embase, Medline, PsycINFO and PSYNDEX - was conducted. Searches were limited to publications between 2000 and April 2014, English and German as languages and humans as study subjects. Results: Our search detected a total of 10,568 studies. Twenty-six studies finally met inclusion criteria. Consumption patterns such as a regular cannabis use independent of social context and an early onset of use (11-15 years) were correlates of cannabis dependence. Moreover, early reactions to cannabis use and coping-oriented use motives explained additional variance. Stress factors and critical life events such as parental separation and early parental death as well as mental and social conflicts have also been linked with development of cannabis dependence. Additionally, comorbid mental disorders correlated with cannabis dependence. Conclusion: Numerous factors were shown to have an impact on transition to cannabis dependence. In particular, a wide range of mental disorders has been linked to an elevated risk of becoming dependent. The development of a dependence syndrome seems to be associated with diverse processes, in which social, biological and intra-individual factors interact in a complex manner. Nevertheless, the link between cannabis dependence and predisposing factors could not be resolved convincingly by most studies due to methodological weaknesses regarding dependence criteria.

1.
Budney AJ, Lile JA: Moving beyond the cannabis controversy into the world of the cannabinoids. Int Rev Psychiatry 2009;21:91-95.
2.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): European drug report 2014: trends and developments. 2014. http://www.emcdda.europa.eu/publications/edr/trends-developments/2014.
3.
Reuter PH: Marijuana legalization: what can be learned from other countries. Santa Monica, RAND: Drug Policy Research Center, 2010. http://www.rand.org/content/dam/rand/pubs/working_papers/2010/RAND_WR771.pdf.
4.
Van den Brink W: Forum: decriminalization of cannabis. Curr Opin Psychiatry 2008;21:122-126.
5.
Bonnet U, Scherbaum N: Cannabisbezogene Störungen. Teil II: Psychiatrische und somatische Folgestörungen und Komorbiditäten [Cannabis use disorders. Part II: psychiatric and somatic sequelae and comorbidities]. Fortschr Neurol Psychiatr 2010;78:360-367; quiz 368.
6.
Soellner R, Gabriel U: Typisch »Kiffer«? Stereotype und Personenwahrnehmung [Typical pothead? Stereotypes and person perception]. Sucht 2008;54:32-37.
7.
Jager G: Cannabis; in Verster J, Brady K, Galanter M, Conrod P (eds): Drug Abuse and Addiction in Medical Illness: Causes, Consequences and Treatment. New York, Springer, 2012, pp 151-162.
8.
Murray RM, Morrison PD, Henquet C, Di Forti M: Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 2007;8:885-895.
9.
Bostwick JM: Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc 2012;87:172-186.
10.
Grotenhermen F, Müller-Vahl K: The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int 2012;109:495-501.
11.
Pacher P, Bátkai S, Kunos G: The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006;58:389-462.
12.
Congressional Research Service: State legalization of recreational marijuana: selected legal issues. 2014. http://fas.org/sgp/crs/misc/R43034.pdf.
13.
Hawken A, Caulkins J, Kilmer B, Kleiman M: Quasi-legal cannabis in Colorado and Washington: local and national implications. Addiction 2013;108:837-838.
14.
Sevigny EL, Pacula RL, Heaton P: The effects of medical marijuana laws on potency. Int J Drug Policy 2014;25:308-319.
15.
Bonnet U, Scherbaum N: Cannabisbezogene Störungen. Teil I: Pharmakologie, Epidemiologie und Therapieverfahren [Cannabis use disorders. Part I: pharmacology, epidemiology and therapy]. Fortschr Neurol Psychiatr 2010;78:297-305.
16.
National Survey on Drug Use and Health (NSDUH): Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. 2012. http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.pdf.
17.
United Nations Office on Drugs and Crime (UNODC): World drug report 2014. https://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf.
18.
Kraus L, Pabst A, Piontek D, Müller S: Trends des Substanzkonsums und substanzbezogener Störungen. Ergebnisse des Epidemiologischen Suchtsurveys 1995-2009 [Trends of substance use and substance use disorders. Results of the 2009 epidemiological survey of substance abuse 1995-2009]. Sucht 2010;56:337-347.
19.
Liebregts N, Benschop A, van Der Pol P, van Laar M, de Graaf R, van den Brink W, Korf DJ: Cannabis dependence and peer selection in social networks of frequent users. Contemporary Drug Problems 2011;38:93-120.
20.
Noack R, Höfler M, Lueken U: Cannabis use patterns and their association with DSM-IV cannabis dependence and gender. Eur Addict Res 2011;17:321-328.
21.
Pabst A, Kraus L, Gomes de Matos E, Piontek D: Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012 [Substance use and substance use disorders in Germany in 2012]. Sucht 2013;59:321-331.
22.
Lopez-Quintero C, Pérez de los Cobos J, Hasin DS, Okuda M, Wang S, Grant BF, Blanco C: Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2010;115:120-130.
23.
Murphy A, Taylor E, Elliott R: The detrimental effects of emotional process dysregulation on decision-making in substance dependence. Front Integr Neurosci 2012;6:101.
24.
American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 2000.
25.
American Psychiatric Association (APA): Substance-related and addictive disorders. American Psychiatric Association, 2013. http://www.dsm5.org/Documents/Substance%20Use%20Disorder%20Fact%20Sheet.pdf.
26.
World Health Organization (WHO): International Statistical Classification of Diseases and Related Health Problems, ed 2. Geneva, WHO, 2004.
27.
Nutt DJ, King LA, Phillips LD; Independent Scientific Committee on Drugs: Drug harms in the UK: a multicriteria decision analysis. Lancet 2010;376:1558-1565.
28.
Van Amsterdam J, Opperhuizen A, Koeter M, Van den Brink W: Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population. Eur Addict Res 2010;16:202-207.
29.
Cascone P, Zimmermann G, Auckenthaler B, Robert-Tissot C: Cannabis dependence in Swiss adolescents: exploration of the role of anxiety, coping styles, and psychosocial difficulties. Swiss J Psychol 2011;70:129-139.
30.
Timberlake DS: A comparison of drug use and dependence between blunt smokers and other cannabis users. Subst Use Misuse 2009;44:401-415.
31.
Taylor DR, Fergusson DM, Milne BJ, Horwood LJ, Moffitt TE, Sears MR, Poulton R: A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002;97:1055-1061.
32.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-269.
33.
van der Pol P, Liebregts N, De Graaf R, Ten Have M, Korf DJ, van den Brink W, van Laar M: Mental health differences between frequent cannabis users with and without dependence and the general population. Addiction 2013;108:1459-1469.
34.
Patton GC, Coffey C, Carlin JB, Sawyer SM, Wakefield M: Teen smokers reach their mid twenties. J Adolesc Health 2006;39:214-220.
35.
Redner R, White TJ, Harder VS, Higgins ST: Vulnerability to smokeless tobacco use among those dependent on alcohol or illicit drugs. Nicotine Tob Res 2014;16:216-223.
36.
Coffey C, Carlin JB, Lynskey M, Li N, Patton GC: Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study. Br J Psychiatry 2003;182:330-336.
37.
Swift W, Coffey C, Carlin JB, Degenhardt L, Patton GC: Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction 2008;103:1361-1370.
38.
Stinson FS, Ruan WJ, Pickering R, Grant BF: Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med 2006;36:1447-1460.
39.
Nocon A, Wittchen HU, Pfister H, Zimmermann P, Lieb R: Dependence symptoms in young cannabis users? A prospective epidemiological study. J Psychiatr Res 2006;40:394-403.
40.
Smucker Barnwell SV, Earleywine M, Gordis EB: Confirming alcohol-moderated links between cannabis use and dependence in a national sample. Addict Behav 2006;31:1695-1699.
41.
Von Sydow K, Lieb R, Pfister H, Höfler M, Wittchen HU: What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend 2002;68:49-64.
42.
Chen CY, O'Brien MS, Anthony JC: Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. Drug Alcohol Depend 2005;79:11-22.
43.
Gao K, Chan PK, Verduin ML, Kemp DE, Tolliver BK, Ganocy SJ, Bilali S, Brady KT, Findling RL, Calabrese JR: Independent predictors for lifetime and recent substance use disorders in patients with rapid-cycling bipolar disorder: focus on anxiety disorders. Am J Addict 2010;19:440-449.
44.
Arria AM, Caldeira KM, O'Grady KE, Vincent KB, Johnson EP, Wish ED: Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy 2008;28:156-169.
45.
Pacek LR, Martins SS, Crum RM: The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. J Affect Disord 2013;148:188-195.
46.
Libby AM, Orton HD, Stover SK, Riggs PD: What came first, major depression or substance use disorder? Clinical characteristics and substance use comparing teens in a treatment cohort. Addict Behav 2005;30:1649-1662.
47.
Kaynak O, Meyers K, Caldeira KM, Vincent KB, Winters KC, Arria AM: Relationships among parental monitoring and sensation seeking on the development of substance use disorder among college students. Addict Behav 2013;38:1457-1463.
48.
Marmorstein NR, Iacono WG: Longitudinal follow-up of adolescents with late-onset antisocial behavior: a pathological yet overlooked group. J Am Acad Child Adolesc Psychiatry 2005;44:1284-1291.
49.
Flory K, Milich R, Lynam DR, Leukefeld C, Clayton R: Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit/hyperactivity disorder and conduct disorder are uniquely at risk. Psychol Addict Behav 2003;17:151-158.
50.
Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM: Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res 2008;42:230-239.
51.
Khantzian EJ: The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-1264.
52.
Swift W, Hall W, Copeland J: One year follow-up of cannabis dependence among long-term users in Sydney, Australia. Drug Alcohol Depend 2000;59:309-318.
53.
Swift W, Coffey C, Carlin JB, Degenhardt L, Calabria B, Patton GC: Are adolescents who moderate their cannabis use at lower risk of later regular and dependent cannabis use? Addiction 2009;104:806-814.
54.
Van der Pol P, Liebregts N, De Graaf R, Korf DJ, Van den Brink W, Van Laar M: Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend 2013;133:352-359.
55.
Fergusson DM, Horwood LJ, Lynskey MT, Madden PA: Early reactions to cannabis predict later dependence. Arch Gen Psychiatry 2003;60:1033-1039.
56.
Le Strat Y, Ramoz N, Horwood J, Falissard B, Hassler C, Romo L, Choquet M, Fergusson D, Gorwood P: First positive reactions to cannabis constitute a priority risk factor for cannabis dependence. Addiction 2009;104:1710-1717.
57.
Blevins CE, Stephens RS, Walker DD, Roffman RA: Situational determinants of use and treatment outcomes in marijuana dependent adults. Addict Behav 2014;39:546-552.
58.
Fox CL, Towe SL, Stephens RS, Walker DD, Roffman RA: Motives for cannabis use in high-risk adolescent users. Psychol Addict Behav 2011;25:492-500.
59.
Liebregts N, van Der Pol P, van Laar M, de Graaf R, van den Brink W, Korf DJ: The role of study and work in cannabis use and dependence trajectories among young adult frequent cannabis users. Front Psychiatry 2013;4:85.
60.
Silver E, Arseneault L, Langley J, Caspi A, Moffitt TE: Mental disorder and violent victimization in a total birth cohort. Am J Public Health 2005;95:2015-2021.
61.
Smucker Barnwell S, Earleywine M, Gordis EB: Alcohol consumption moderates the link between cannabis use and cannabis dependence in an internet survey. Psychol Addict Behav 2005;19:212-216.
62.
Johnson K, Mullin JL, Marshall EC, Bonn-Miller MO, Zvolensky M: Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. Am J Addict 2010;19:277-282.
63.
Zvolensky MJ, Bernstein A, Sachs-Ericsson N, Schmidt NB, Buckner JD, Bonn-Miller MO: Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. J Psychiatr Res 2006;40:477-486.
64.
Chabrol H, Ducongé E, Casas C, Roura C, Carey KB: Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav 2005;30:829-840.
65.
Clark CB, Perkins A, McCullumsmith CB, Islam MA, Hanover EE, Cropsey KL: Characteristics of victims of sexual abuse by gender and race in a community corrections population. J Interpers Violence 2012;27:1844-1861.
66.
Dorard G, Berthoz S, Phan O, Corcos M, Bungener C: Affect dysregulation in cannabis abusers: a study in adolescents and young adults. Eur Child Adolesc Psychiatry 2008;17:274-282.
67.
Lynskey MT, Heath AC, Nelson EC, Bucholz KK, Madden PA, Slutske WS, Statham DJ, Martin NG: Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol Med 2002;32:195-207.
68.
Lynskey MT, Glowinski AL, Todorov AA, Bucholz KK, Madden PA, Statham DJ, Martin NG, Heath AC: Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry 2004;61:1026-1032.
69.
Mathews RR, Hall WD, Gartner CE: Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing. Med J Aust 2011;195:S12-S15.
70.
Noack R, Höfler M, Gründler R, Becker A, Schulz R, Paul K: Konsummuster als Kovariablen von DSM-IV Cannabisabhängigkeit [Relationships between cannabis use patterns and DSM-IV cannabis dependence]. Sucht 2009;55:137-147.
71.
Ream GL, Benoit E, Johnson BD, Dunlap E: Smoking tobacco along with marijuana increases symptoms of cannabis dependence. Drug Alcohol Depend 2008;95:199-208.
72.
Chen CY, Anthony JC: Possible age-associated bias in reporting of clinical features of drug dependence: epidemiological evidence on adolescent-onset marijuana use. Addiction 2003;98:71-82.
73.
Swift W, Hall W, Didcott P, Reilly D: Patterns and correlates of cannabis dependence among long-term users in an Australian rural area. Addiction 1998;93:1149-1160.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.